Robert Tissue compensation by year
Summit Financial Summary Compensation Table · all 3 fiscal years held| Component | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Salary | $281,250 | $297,750 | $314,750 |
| Bonus | — | — | $0 |
| Stock awards | — | — | $0 |
| Option awards | — | $160,810 | $0 |
| Non-equity incentive | $153,196 | $169,290 | $187,911 |
| Pension and deferred compensation | $29,226 | $32,786 | $420,833 |
| All other | $24,613 | $24,900 | $30,358 |
| Total | $488,285 | $685,536 | $953,852 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Summit Financial Group, Inc. DEF 14A filed March 31, 2023, accession 0001437749-23-008698, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Summit Financial Group, Inc. filed document, accession 0001437749-23-008698. Every figure is read from that document and cited to the page and table it appears in. Filed March 31, 2023.
Equity holdings
unvested awards at FY2022 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 10,231 | $40,924 | — |
| RSU | 3,444 | $13,776 | — |
| RSU | 10,768 | — | — |
| RSU | 8,151 | — | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Summit Financial Group, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
9 Form 4 lines since the FY2022 proxy (filed March 31, 2023)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2024-05-03 | Disposition to the issuer | — | 740 | — | 0 |
| 2024-05-03 | Disposition to the issuer derivative | — | 16,730 | — | 0 |
| 2024-05-03 | Other | — | 1,152.05 | $0.00 | 19,562.52 |
| 2024-05-03 | Disposition to the issuer | — | 19,562.52 | — | 0 |
| 2024-05-03 | Disposition to the issuer | — | 59,997 | — | 0 |
| 2024-05-03 | Disposition to the issuer derivative | — | 10,768.2 | — | 0 |
| 2024-05-03 | Disposition to the issuer derivative | — | 8,151 | — | 0 |
| 2024-05-03 | Disposition to the issuer derivative | — | 17,052 | — | 0 |
The 8 most recent of 9 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Summit Financial’s named executive officers, FY2022
as the company reported each| Named executive officer | Role | FY2022 total |
|---|---|---|
| H. Charles Maddy III | President and Chief Executive Officer | $1,039,986 |
| Patrick Frye | Executive Vice President and Chief of Credit Administration | $1,017,853 |
| Robert Tissue · this page | Executive Vice President and Chief Financial Officer | $953,852 |
| Bradford Ritchie | President – Summit Community Bank | $622,971 |
| Scott Jennings | Executive Vice President Chief Operating Officer – Summit Financial Group | $602,308 |
The full Summit Financial compensation record
free company briefThis page is one person within Summit Financial's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Summit Financial's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.